81 related articles for article (PubMed ID: 1458168)
1. [The selectivity and protective properties of m-cholinolytics in dichlorodivinylphosphate poisoning].
Kosmachev AB; Iankhotova MB; Kosmacheva IM
Eksp Klin Farmakol; 1992; 55(3):56-8. PubMed ID: 1458168
[TBL] [Abstract][Full Text] [Related]
2. [The role of the blockade of separate subtypes of muscarinic receptors in realizing the antidotal effect of m-cholinolytics in dimethyl dichlorovinyl phosphate poisoning].
Kosmachev AB; Beliaev VA; Fil'ko OA; Podosinovikova NP; Solov'eva NE; Titkova TA
Eksp Klin Farmakol; 1999; 62(4):55-8. PubMed ID: 10513339
[TBL] [Abstract][Full Text] [Related]
3. [The possible role of presynaptic effects in realizing the protective action of M-cholinolytics in dimethyl dichlorovinyl phosphate poisoning].
Kosmachev AB; Filippov VN; Kosmacheva IM; Khobotova ZI; Kuleshov VI
Farmakol Toksikol; 1991; 54(4):67-9. PubMed ID: 1664807
[TBL] [Abstract][Full Text] [Related]
4. [The role of blockage of various M-cholinoreceptor subtypes in induction of tachycardia in rats].
Kosmachev AB; Lychakov AV; Saunkina IuA; Fil'ko OA; Chigareva SM
Eksp Klin Farmakol; 1997; 60(5):44-6. PubMed ID: 9483405
[TBL] [Abstract][Full Text] [Related]
5. [Relationship between the choline-blocking and protective actions of m-cholinolytics in chlorophos poisoning].
Kosmachev AB; Petrov VV; Chigareva SM
Farmakol Toksikol; 1988; 51(3):25-7. PubMed ID: 3410021
[TBL] [Abstract][Full Text] [Related]
6. [The mechanisms of the antidotal action of bispyridinium oximes when used in combination with M-cholinolytics in dimethyl dichlorovinyl phosphate poisoning].
Filipppov VN; Podosinovikova NP; Kosmachev AB; Dolgo-Saburov VB
Eksp Klin Farmakol; 1993; 56(6):57-8. PubMed ID: 8111302
[TBL] [Abstract][Full Text] [Related]
7. [The role of endogenous K+ in realizing the protective action of M-cholinolytics in chlorophos poisoning].
Kosmachev AB; Kosmacheva IM; Fil'ko OA; Luleshov VI
Eksp Klin Farmakol; 1992; 55(2):55-8. PubMed ID: 1422458
[TBL] [Abstract][Full Text] [Related]
8. [The selectivity of the action of muscarinic agonists in vivo].
Kosmachev AB; Kosmacheva IM; Iankhotova MV; Kuleshov VI
Eksp Klin Farmakol; 1994; 57(2):6-8. PubMed ID: 8205054
[TBL] [Abstract][Full Text] [Related]
9. [Effect of M3-choline receptor blockade on the ability of muscarinic antagonists to prevent catalepsy induced by haloperidol in rats].
Kosmachev AB; Beliaev VA; Khrabrova AV; Libman NM; Dolgo-Saburov VB
Eksp Klin Farmakol; 2001; 64(4):10-2. PubMed ID: 11589099
[TBL] [Abstract][Full Text] [Related]
10. [The antiparkinson activity of muscarinic antagonists depending on their selectivity for individual m-cholinoreceptor subtypes].
Kosmachev AB; Beliaev VA; Khrabrova AV; Fil'ko OA; Libman NM
Eksp Klin Farmakol; 1998; 61(5):3-5. PubMed ID: 9854621
[TBL] [Abstract][Full Text] [Related]
11. [The ambiguous nature of the action of m-cholinolytics in chlorophos poisoning].
Kosmachev AB; Kosmacheva IM; Chigareva SM
Farmakol Toksikol; 1988; 51(5):86-9. PubMed ID: 3208890
[TBL] [Abstract][Full Text] [Related]
12. [The characteristics of the effect of imperialone on the M-cholinoreceptors of different organs].
Mirzaev IuR; Plotnikova IT; Shakirov R
Eksp Klin Farmakol; 1993; 56(4):14-7. PubMed ID: 8220005
[TBL] [Abstract][Full Text] [Related]
13. [Effect of pH on muscarinic antagonist selectivity].
Kosmachev AB; Iakhontova MB; Titkova TA; Fil'ko OA; Ramsh SM
Eksp Klin Farmakol; 2001; 64(3):29-32. PubMed ID: 11558434
[TBL] [Abstract][Full Text] [Related]
14. [The role of the muscarinic receptors in the pathogenesis of the convulsive state induced by korazol in rats].
Khobotova ZI; Mukovskiĭ LA; Kosmachev AB; Fil'ko OA; Filippov VN; Dolgo-Saburov VB
Eksp Klin Farmakol; 1997; 60(1):16-8. PubMed ID: 9162273
[TBL] [Abstract][Full Text] [Related]
15. Distinct kinetic binding properties of N-[3H]-methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brain.
Flynn DD; Mash DC
Synapse; 1993 Aug; 14(4):283-96. PubMed ID: 8248852
[TBL] [Abstract][Full Text] [Related]
16. [Effect of biotransformation on the receptor selectivity of muscarinic antagonists in vivo].
Kosmachev AB; Titkova TA; Fil'ko OA; Libman NM
Eksp Klin Farmakol; 2000; 63(4):13-6. PubMed ID: 11022298
[TBL] [Abstract][Full Text] [Related]
17. Treatment of the stressogenic effect of dichlorvos.
Kassa J; Bajgar J
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1994; 37(1):29-32. PubMed ID: 7761789
[TBL] [Abstract][Full Text] [Related]
18. The relative selectivity of anticholinergic drugs for the M1 and M2 muscarinic receptor subtypes.
Burke RE
Mov Disord; 1986; 1(2):135-44. PubMed ID: 2904117
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological properties of (2R)-N-[1-(6-aminopyridin-2-ylmethyl)piperidin-4-yl]-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: a novel mucarinic antagonist with M(2)-sparing antagonistic activity.
Hirose H; Aoki I; Kimura T; Fujikawa T; Numazawa T; Sasaki K; Sato A; Hasegawa T; Nishikibe M; Mitsuya M; Ohtake N; Mase T; Noguchi K
J Pharmacol Exp Ther; 2001 May; 297(2):790-7. PubMed ID: 11303071
[TBL] [Abstract][Full Text] [Related]
20. Selective antagonists reveal different functions of M cholinoceptor subtypes in humans.
Pitschner HF; Schlepper M; Schulte B; Volz C; Palm D; Wellstein A
Trends Pharmacol Sci; 1989 Dec; Suppl():92-6. PubMed ID: 2694532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
